Brief: Moberg Pharma: OncoZenge Raises SEK 10 Mln Ahead Of Spin-Off And Separate Listing

Moberg Pharma AB (publ)

11/12/2020 07:11

Dec 11 (Reuters) - Moberg Pharma AB (publ)  MBPH.ST :
    * ONCOZENGE RAISES MSEK 10 AHEAD OF SPIN-OFF AND SEPARATE
LISTING
    * ONCOZENGE AB (PUBL) ("ONCOZENGE"), MOBERG PHARMA AB
(PUBL)'S
SUBSIDIARY, HAS TODAY RESOLVED ON A DIRECTED SHARE ISSUE
    * DIRECTED ISSUE OF MSEK 10 IS FIRST STEP OF SECURED
FINANCING IN
ONCOZENGE OF MSEK 70 IN TOTAL
    * SHARE ISSUE IS CARRIED OUT TO SECURE ONCOZENGE'S INITIAL
WORKING
CAPITAL REQUIREMENTS AHEAD OF LISTING ON NASDAQ FIRST NORTH
GROWTH MARKET, WHICH IS PLANNED TO TAKE PLACE DURING Q1 OF 2021
    * FOR FINANCING OF AN UPCOMING CLINICAL PHASE 3 STUDY AND
OTHER
ACTIVITIES, ONCOZENGE ALSO INTENDS TO CARRY OUT A FULLY
GUARANTEED RIGHTS ISSUE, WHICH IS EXPECTED TO RAISE
APPROXIMATELY MSEK 60 TO COMPANY BEFORE COSTS

Source text for Eikon:  ID:nWkr287nM0 
Further company coverage:  MBPH.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))